tiprankstipranks
Biomarin Pharmaceutical Inc. (DE:BM8)
NASDAQ:BM8

Compare BioMarin Pharmaceutical (BM8) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BioMarin Pharmaceutical
€48.13
€9.43B
32.67
-8.70%
13 Buy
3 Hold
0 Sell
Strong Buy
Jazz Pharmaceuticals
$195.93
$12.06B
12.74
90.56%
12 Buy
0 Hold
0 Sell
Strong Buy
PTC Therapeutics
$71.26
$5.90B
8.85
79.18%
8 Buy
4 Hold
0 Sell
Moderate Buy
Ultragenyx Pharmaceutical
$23.15
$2.24B
-3.94
-25.47%
17 Buy
2 Hold
0 Sell
Strong Buy
Summit Therapeutics
$18.81
$14.58B
-12.11
13.04%
9 Buy
2 Hold
0 Sell
Strong Buy
Immunovant
$24.73
$5.03B
-10.43
85.80%
10 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:BM8
BioMarin Pharmaceutical
49.65
-0.33
-0.66%
JAZZ
Jazz Pharmaceuticals
195.93
85.81
77.92%
PTCT
PTC Therapeutics
71.26
28.51
66.69%
RARE
Ultragenyx Pharmaceutical
23.15
-10.76
-31.73%
SMMT
Summit Therapeutics
18.81
0.58
3.18%
IMVT
Immunovant
24.73
9.83
65.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts